Prothrombin fragment 1+2 during oral anticoagulation in congenital nephrotic syndrome.
Mache
C J
CJ
Muntean
W
W
Resch
B
B
Ring
E
E
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D002648:Child; D006801:Humans; D009404:Nephrotic Syndrome / Q000097:blood* / Q000151:congenital; D010446:Peptide Fragments / Q000378:metabolism*; D011516:Prothrombin / Q000378:metabolism*
D000925:Anticoagulants; D015415:Biomarkers; D010446:Peptide Fragments; C045879:prothrombin fragment 1.2; D011516:Prothrombin